PICCIRILLI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 2.737
EU - Europa 1.265
AS - Asia 1.153
SA - Sud America 227
AF - Africa 33
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.420
Nazione #
US - Stati Uniti d'America 2.680
SG - Singapore 556
RU - Federazione Russa 543
BR - Brasile 198
CN - Cina 166
VN - Vietnam 152
DE - Germania 150
IE - Irlanda 150
HK - Hong Kong 125
IT - Italia 108
FI - Finlandia 78
FR - Francia 54
NL - Olanda 51
IN - India 38
GB - Regno Unito 35
CA - Canada 28
TR - Turchia 23
MX - Messico 21
BD - Bangladesh 19
ES - Italia 16
UA - Ucraina 16
JP - Giappone 15
SE - Svezia 12
PL - Polonia 11
ZA - Sudafrica 10
CZ - Repubblica Ceca 9
ID - Indonesia 9
LT - Lituania 9
EC - Ecuador 8
AR - Argentina 7
IQ - Iraq 7
UZ - Uzbekistan 7
PK - Pakistan 6
BE - Belgio 5
AT - Austria 4
JM - Giamaica 4
KG - Kirghizistan 4
KR - Corea 4
MA - Marocco 4
PH - Filippine 4
AU - Australia 3
CO - Colombia 3
CR - Costa Rica 3
SA - Arabia Saudita 3
TN - Tunisia 3
UY - Uruguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
ET - Etiopia 2
GA - Gabon 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
PE - Perù 2
SN - Senegal 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
GR - Grecia 1
IL - Israele 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
MN - Mongolia 1
MY - Malesia 1
NE - Niger 1
NZ - Nuova Zelanda 1
PY - Paraguay 1
RO - Romania 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
VG - Isole Vergini Britanniche 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.420
Città #
Dallas 988
Singapore 372
San Jose 302
Ashburn 200
Chandler 198
Dublin 150
Hong Kong 122
Santa Clara 111
New York 85
Munich 69
The Dalles 69
Boardman 65
Jacksonville 57
Moscow 52
Ho Chi Minh City 50
Los Angeles 47
Hanoi 42
Turku 42
Beijing 31
Orem 31
São Paulo 29
Lauterbourg 28
Helsinki 26
Bremen 21
Chennai 21
Hefei 21
Lawrence 20
Princeton 20
Council Bluffs 18
Denver 18
Falkenstein 18
Milan 17
Shanghai 15
Tokyo 14
Izmir 13
L’Aquila 13
Rome 13
Atlanta 12
West Jordan 12
Amsterdam 11
Brooklyn 11
Columbus 11
Montreal 11
Wilmington 11
Da Nang 9
Penne 9
Seattle 9
Warsaw 9
Assago 8
Brno 8
Dong Ket 8
Houston 8
Phoenix 8
Stockholm 8
Boston 7
Düsseldorf 7
Lappeenranta 7
Mexico City 7
Ningbo 7
Tashkent 7
Toronto 7
Ankara 6
Brasília 6
Frankfurt am Main 6
Jakarta 6
London 6
Mumbai 6
Nanjing 6
Poplar 6
Belo Horizonte 5
Brussels 5
Chicago 5
Dhaka 5
Goiânia 5
Johannesburg 5
Manchester 5
Paris 5
Roseto degli Abruzzi 5
San Francisco 5
San Mateo 5
Bishkek 4
Cagliari 4
Calgary 4
L'aquila 4
New Delhi 4
Ninh Bình 4
Nuremberg 4
Rio de Janeiro 4
Sorocaba 4
Baghdad 3
Berlin 3
Campinas 3
Caracas 3
Charlotte 3
Curitiba 3
Duque de Caxias 3
Edinburgh 3
Florianópolis 3
Guayaquil 3
Haiphong 3
Totale 3.792
Nome #
First Identification of β-Lactamases in Antibiotic-Resistant Escherichia coli, Citrobacter freundii, and Aeromonas spp. Isolated in Stream Macroinvertebrates in a Central Italian Region. 164
Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease 154
Inhibitory Potential of Polyclonal Camel Antibodies against New Delhi Metallo-β-lactamase-1 (NDM-1). 146
Amino acid replacement at position 228 induces fluctuation in the Ω-loop of KPC-3 and reduces the affinity against oxyimino cephalosporins: Kinetic and molecular dynamics studies 145
Kinetic studies on CphA mutants reveal the role of the P158-P172 loop in activity versus carbapenems 143
Exploring the role of l10 loop in new delhi metallo-β-lactamase (Ndm-1): Kinetic and dynamic studies 142
Potent inhibitory activity of taniborbactam towards NDM-1 and NDM-1Q119X mutants, and in vitro activity of cefepime/taniborbactam against MBLs producing Enterobacterales 139
Interaction of carbapenems and β-lactamase inhibitors towards CTX-M-15 and CTX-M-15G238Cmutant 138
Kinetic profile and molecular dynamic studies show that Y229W substitution in an NDM-1/L209F variant restores the hydrolytic activity of the enzyme toward penicillins, cephalosporins, and carbapenems 138
P174E substitution in GES-1 and GES-5 β-lactamases improves catalytic efficiency towards carbapenems. 133
Molecular characterization of carbapenem-resistant Klebsiella pneumoniae ST14 and ST512 causing bloodstream infections in ICU and surgery wards of a tertiary University hospital of Verona (Northern Italy): co-production of KPC-3, OXA-48, and CTX-M-15 β-lactamases. 132
Laboratory variants GESG170L, GESG170K, and GESG170H increase carbapenem hydrolysis and confer resistance to clavulanic acid 127
In vitro Activity of Cefiderocol and Comparator Agents tested against Carbapenem-Resistant Acinetobacter baumannii (CRAb) from six Italian laboratories. 126
Effect of V88L, M154L and A233V amino acid substitutions on NDM-1 metallo-β-lactamase: kinetic and dynamic studies. 123
Resistome and Virulome of Multi-Drug Resistant E. coli ST131 Isolated from Residents of Long-Term Care Facilities in the Northern Italian Region 123
A Two Amino Acid Duplication, L167E168, in the X-Loop Drastically Decreases Carbapenemase Activity of KPC-53, a Natural Class A β-Lactamase 122
Multi-drug resistant Enterobacter cloacae ST145 causing bloodstream infection in a hospitalized patient: molecular characterization of resistome and virulome. 111
Evaluation of the Analytical Performances of the Biolabo SOLEA 100 Optical Coagulometer and Comparison with the Stago STA-R MAX Analyser in the Determination of PT, APTT, and Fibrinogen 110
Coexistence of blaNDM-5, blaCTX-M-15, blaOXA-232, blaSHV-182 genes in multidrug-resistant K. pneumoniae ST437-carrying OmpK36 and OmpK37 porin mutations: First report in Italy 110
TEM-184, a Novel TEM-Derived Extended-Spectrum β-Lactamase with Enhanced Activity against Aztreonam 110
Whole-Genome Sequencing (WGS) of Carbapenem-Resistant K. pneumoniae Isolated in Long-Term Care Facilities in the Northern Italian Region 107
Exploiting Bacteria for Improving Hypoxemia of COVID-19 Patients 105
In Vitro Activity of Sulbactam–Durlobactam against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: A Multicentre Report from Italy 104
The crosstalk between gut barrier impairment, mitochondrial dysfunction, and microbiota alterations in people living with HIV 104
Camel-Derived Nanobodies as Potent Inhibitors of New Delhi Metallo-β-Lactamase-1 Enzyme 101
Identification of CTX-M-15 and CTX-M-27 in Antibiotic-Resistant Gram-Negative Bacteria Isolated from Three Rivers Running in Central Italy. 101
In vitro Activity of Cefiderocol against carbapenemases-OXA-type producing Acinetobacter baumannii clinical strains: a report of six Italian laboratories 99
Oxygen sparing effect of bacteriotherapy in covid-19 99
Whole-Genome Sequencing of ST2 A. baumannii Causing Bloodstream Infections in COVID-19 Patients 98
Biochemical and molecular characterization of GES and NDM engineered variants: interactions with β-lactams and inhibitors 98
Identification of IncA Plasmid, Harboring blaVIM-1 Gene, in S. enterica Goldcoast ST358 and C. freundii ST62 Isolated in a Hospitalized Patient 97
Polyimidazole ligands: Copper(II) complexes and antiproliferative activity in cancer cells 95
Evaluation of cefiderocol stability against clinically relevant serine- and metallo-β-lactamases 95
Polyimidazole ligands: biological activity of their copper complexes 94
Molecular Characterization by Whole-Genome Sequencing of Clinical and Environmental Serratia marcescens Strains Isolated during an Outbreak in a Neonatal Intensive Care Unit (NICU) 92
Analysis of Antimicrobial Resistance Genes (ARGs) in Enterobacterales and A. baumannii Clinical Strains Colonizing a Single Italian Patient 91
New polyimidazole ligands against subclass B1 metallo-β-lactamases: Kinetic, microbiological, docking analysis 91
Synergistic Activity of Temocillin and Fosfomycin Combination against KPC-Producing Klebsiella pneumoniae Clinical Isolates 88
Biofilm formation among Stenotrophomonas Maltophilia isolates has clinical relevance: The ANSELM prospective multicenter study 87
Whole-genome sequencing of OXA-232 carbapenemase-producing ST437 K. pneumoniae high-risk CG258 clone. 86
Biochemical characterization of SHV-134 extended-spectrum β-lactamase identified in K. pneumoniae clinical strain. 84
First identification of VIM-1 in blood stream carbapenem-resistant Salmonella enterica ST358 serovar Goldcoast. 84
Repurposing High-Throughput Screening Identifies Unconventional Drugs with Antibacterial and Antibiofilm Activities against Pseudomonas aeruginosa under Experimental Conditions Relevant to Cystic Fibrosis 79
Biological studies of copper complexes based on polyimidazole ligands 79
Nanobody-based strategy as alternative to tackle resistance to range of bacterial antibiotics. 78
Selection and characterization of anti-NDM-1 nanobodies. 74
The in vitro inhibitory activity of polypyridine ligands towards subclass B1 metallo-β-lactamases 72
Deciphering the Role of V88L Substitution in NDM-24 Metallo-β-Lactamase 67
Molecular and Kinetic Characterization of MOX-9, a Plasmid-Mediated Enzyme Representative of a Novel Sublineage of MOX-Type Class C β-Lactamases 65
Giving Drugs a Second Chance: Antibacterial and Antibiofilm Effects of Ciclopirox and Ribavirin against Cystic Fibrosis Pseudomonas aeruginosa Strains 60
New Antimicrobials for Gram-Positive Sustained Infections: A Comprehensive Guide for Clinicians 57
Acinetobacter baumannii Resistance to Sulbactam/Durlobactam: A Systematic Review 48
Enzyme graphene oxide interaction: the case system of β-lactamases 30
OXA-carbapenemases and mutations within PBPs in ST2 carbapenem-resistant A. baumannii: Evaluating the efficacy of cefiderocol and ampicillin-sulbactam combination therapy 29
Escherichia coli producing AmpC DHA-1 bacteraemia in neutropenic leukemic patient: continuous infusion ceftazidime/avibactam as a carbapenem sparing regimen 27
Evaluation of the Biolabo Turbidimetric Assay for Automated Determination of Haemoglobin A1c 27
Discovery of Boronic Acids-Based β-Lactamase Inhibitors Through In Situ Click Chemistry 26
Totale 5.554
Categoria #
all - tutte 20.684
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.684


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202124 0 0 0 0 0 0 0 0 0 0 15 9
2021/2022110 0 0 4 4 5 9 2 32 3 0 5 46
2022/2023481 31 43 8 67 43 47 0 37 183 4 16 2
2023/2024293 12 18 34 16 19 77 8 26 14 27 16 26
2024/20251.222 75 21 84 52 117 93 220 90 199 56 127 88
2025/20263.242 119 306 829 358 307 161 339 90 318 415 0 0
Totale 5.554